Barely Significant
← all excerpts

The GlycoPaSER Prototype as a Real-Time N-Glycopeptide Identification Tool Based on the PaSER Parallel Computing Platform.

Int J Mol Sci · 2023 · PMC10178020 · PMID 37175577

1
hedged sentence
closest p
boldest claim

The sentences

highly significantno p-value reported
Spectral decomposition of the glycopeptide spectrum into peptide and glycan moiety composite spectra enables the subsequent identification of each moiety with a highly significant overlap between our GlycoPaSER prototype and MSFragger-Glyco results.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.